Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

294 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Completed

A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

NCT03289962

Conditions
Bladder Cancer, Breast Diseases, Breast Neoplasms, +48 more
Locations
  • HonorHealth Research Institute ? Bisgrove Scottsdale, Arizona, United States
  • The Los Angeles Clinic Los Angeles, California, United States
  • UCSF Comprehensive Cancer Ctr San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 33 locations
View Trial Details
Completed

Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.

NCT05181462

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Hospital Universitario Virgen de las Nieves Granada, Andalusia, Spain
  • Hospital Universitario Clinico San Cecilio Granada, Andalusia, Spain
  • Complejo Hospitalario de Jaén Jaén, Andalusia, Spain
  • Hospital Universitario Virgen De La Victoria Málaga, Andalusia, Spain
View all 23 locations
View Trial Details
Completed

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

NCT03797326

Conditions
Adnexal Diseases, Advanced Solid Tumors, Astrocytoma, +49 more
Locations
  • City of Hope ( Site 0002) Duarte, California, United States
  • Cedars Sinai Medical Center ( Site 0003) Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center ( Site 0005) Sacramento, California, United States
  • University of Colorado, Anschutz Cancer Pavilion ( Site 0007) Aurora, Colorado, United States
View all 88 locations
View Trial Details
Completed

NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

NCT04332653

Conditions
Adnexal Diseases, Any Advanced Solid Tumors, Breast Diseases, +41 more
Locations
  • Moffit Cancer Center Tampa, Florida, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University School of Medicine in St. Louis St Louis, Missouri, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer

NCT03301350

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Swedish American Hospital Rockford, Illinois, United States
  • University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
  • Columbia St. Mary's Cancer Center Milwaukee, Wisconsin, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors

NCT05001347

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +36 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Medical Oncology Hematology Consultants, PA Newark, Delaware, United States
  • Illinois Cancer Specialists Arlington Heights, Illinois, United States
View all 15 locations
View Trial Details
Completed

Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED

NCT05520723

Conditions
Advanced HR+/HER2- Breast Cancer, Breast Cancer, Breast Diseases, +7 more
Locations
  • Hospital Universitario A Coruña A Coruña, A Coruna, Spain
  • Hospital Universitario General de Catalunya Sant Cugat del Vallès, Barcelona, Spain
  • Hospital Universitario Donostia San Sebastián, Donostia, Spain
  • Hospital Arnau de Vilanova Lleida, Spain
View Trial Details

Related conditions